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Induction of tolerance for skin allotransplantation requires 
selective suppression of the host response to foreign histo- 
compatibility antigens. This report describes a new approach 
that employs pretreatment of effector cells with 8-methoxy- 
psoralen (8-MOP) and ultraviolet A light (UVA) to render 
the effector cells of graft rejection immunogenic for the syn- 
geneic recipient. Reinfusion of photodamaged cells resulted 
in an immunosuppressive host response that permitted pro- 
longed retention of histoincompatible skin grafts and specifi- 
cally inhibited in vitro and in vivo responses that correlate 
with allograft rejection. 
Eight days after BALB/c mice received CBA/j skin grafts, 
their splenocytes served as a source of alloreactive effector 
cells. The splenocytes were treated with 100 ng/ml8-MOP 
and 1 J/cm2 UVA before reinfusion into naive BALB/c re- 
cipients. Recipient mice were tested for tolerance to alloanti- 
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delayed type hypersensitivity assays (DTH), and challenge 
with a fresh CBA/j graft. 
Splenocytes from BALB/ c recipients of 
splenocytes containing the effector cells o P 
hotoinactivated 
CBA/j alloanti- 
gen rejection proliferated poorly in MLC and generated 
lower cytotoxic T cell responses to CBA/j alloantigens in 
comparison with sensitized and naive controls. Splenocytes 
from these hyporesponsive mice suppressed the MLC and 
CTL response to alloantigen from sensitized and naive 
BALB/c mice. In vivo the DTH response was specifically 
suppressed to the relevant alloantigen in compa&on with 
controls. Moreover, BALB/c mice treated in this fashion 
retained a CBA/j skin graft for up to 42 d posttransplantation 
without visual evidence of rejection. These results indicate 
that the in vivo and in vitro response to alloantigen can be 
attenuated by pretreating the host with photoinactivated 
splenocytes containing the effector cells of alloantigen rejec- 
tion.] Invest Dermatol 92:669- 676, 1989 
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I 
he capacity to down regulate selectively aberrant T 
cell uonulations is an important goal of immunother- 
apy.B&orts have been made in a laboratory model of 
A 
autoreactive disease in which cloned antimyelin basic 
protein T cells induce experimental autoimmune en- 
cephalomyelitis‘(EAE) in susceptible strains of rodents [ 11. Cohen et 
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Abbreviations: 
8-MOP: 8-methoxypsoralen 
APC: antigen presenting cells 
Con A: concanavalin A 
DTH: delayed type hypersensitivity 
EAE: experimental autoimmune encephalomyelitis 
MLC: mixed leukocyte culture 
PBS: phosphate-buffered saline 
PET: photoinactivated effector T cells 
Tc: effector T cells of cytotoxic response 
Tdth: effector T cells of delayed type hypersensitivity 
UVA: ultraviolet A light 
al [2,3] have shown that if these pathogenic cloned T cells are 
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fluidity (such as hydrostatic pressure) and then intravenously rein- 
fused, they can immunoprotect syngeneic animals in a clonotypic 
manner against the same autoreactive disease. 
Several obstacles currently preclude application of the Cohen 
approach to treatment of human diseases, reflecting increased num- 
bers or activity of pathogenic T cells. First, isolation and in vitro 
expansion of such clones is severely impeded by difficulties in iden- 
tifying the aberrant T clones. Second, it is likely that laborious in 
vitro manipulations would be required for each individual patient’s 
unique 
P 
athogenic clones. Finally, it would be necessary that the 
mode o cell treatment be less systemically toxic than standard ther- 
apies currently available. 
Recently, we have reported that cutaneous T cell lymphoma pa- 
tients that received intravenous reinfusion of mononuclear cells, 
which have been extracorporeally exposed to %methoxypsoralen 
(8-MOP) in the presence of ultraviolet A light (UVA), demon- 
strated a profound and prolonged clinical response that appears to be 
immunologically mediated [4]. It is noteworthy that no in vitro 
manipulations of cells were required and that systemic toxicity was 
quite limited. If it can be demonstrated that this clinically practical 
therapy leads to a specific regulatory T cell response, a potentially 
significant therapeutic principle may have been recognized: unfrac- 
tionated populations of autologous mononuclear cells containing an 
expanded clone(s) of pathogenic T cells can vaccinate against the 
.~~ ..~ 
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activity of the same clone(s) if extracorporeally altered in an appro- 
priate fashion. 
To test this possibility, the following experiments were con- 
ducted to determine whether preexposure of BALB/c mice im- 
mune system to splenocytes obtained from other BALB/c mice 
undergoing rejection of CBA/j skin grafts and inactivated with 
8-MOP photoactivated by UVA light, would render the syngeneic 
recipients unresponsive to the CBA/j alloantigens. In this report we 
show that preexposure of the mouse immune system to cells gener- 
ated during skin transplant rejection and photoinactivated with 
8-MOP and UVA can be one way to render the secondary syngeneic 
recipients relatively tolerant to the alloantigen carried by the origi- 
nal skin transplant. 
MATERIAL9 AND _METHODS _.__--- -_____L .-- .- 
Mice BALB/cBYJ (H-2d, Mlsb), CBA/j (H-2k, Mlsd), and 
C57BL/lO (H-2b, Mlsb) mice were purchased from The Jackson 
Laboratory, Bar Harbor, ME. All mice were maintained in a specific 
pathogen-free facility. Female CBA/j mice, 4 to 6 wk of age, were 
used as skin transplant donors. Female BALB/c mice, 4 to 6 wk of 
age, were the skin transplant recipients. C57BL/lO (H-2b, MLsb) 
female mice were the donors of splenocytes used as the irrelevant 
alloantigen control in in vitro and in vivo experiments. 
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The skin grafting was 
P 
erformed following the procedure of Bil- 
lingham and Medawar 51. The truncal skin of donor mice (CBA/j) 
was shaved and the animals were killed. Full thickness skin was 
obtained by sharp dissection of truncal skin, followed by removal of 
fat and panniculus carnosus by blunt dissection. Skin graft recipient 
mice (BALB/C) were shaved and anesthetized intramuscularly with 
0.01 ml of ketamine hydrochloride (100 mg/ml) diluted 10: 1 with 
xylasine (20 mg/ml). A circular piece of skin measuring approxi- 
mately 1 X 1 cm was removed from each recipient mouse down to 
fascia from the grafting site. The grafts were ap lied to the fascia 
and sutured with Vycril 3-O suture (Ethicon, Jo K nson &Johnson 
Co., Summerville, NJ). Rejection was allowed to take place. 
Spleens were removed from the mice undergoing allograft rejec- 
tion, 8, 12, and 15 d after transplant. Single-cell suspensions were 
prepared by pressing the tissues with blunt curved forceps. Red 
blood cells were lysed with 0.83% NH&l. After two washings, 
ceiis were adjusted to the appropriate concentration in phosphate- 
buffered saline (PBS) for injections (see immunization protocol) or 
media [culture media consisting of RPM1 1640 supplemented with 
20mM Hepes buffer, 2mM glutamine, 5% heat inactivated fetal calf 
serum (all from Gibco, Grand Island, New York), 5 X 10”M 2- 
mercaptoethanol, 100 pg/ml streptomycin, and 100 U/ml penicil- 
lin] for assays (see Mixed Leukocyte Culture and Cytotoxicity 
Assay). The cell suspension was 89% viable as determine by trypan 
blue exclusion. Mean spleen cell yield was calculated for all spleno- 
cytes obtained from BALB/c mice undergoing CBA/j skin allograft 
rejection, and cytotoxicity assays were performed at the different 
time intervals mentioned (see Cytotoxicity Assay). Degree of rejec- 
tion was defined as the product of mean cell yield and the highest 
cytotoxic response obtained. By this definition, the peak of rejection 
was considered to be 8 d posttransplant. Splenocytes obtained from 
these transplanted (sensitized) mice served as a source of the im- 
munizing population of cells. 
Photoinactivation Optimal conditions for murine splenocyte 
photoinactivation, as determined by their proliferative response to 
nonspecific mitogens, has been reported elsewhere [6]. The 8-MOP 
(Elder Pharmaceutical, Costa Mesa, CA) was dissolved in 100% 
ethanol and subsequently in PBS. Splenocytes from BALB/c mice 
rejecting CBA/j skin graft were incubated in 100 ng/ml of 8-MOP 
in shielded tubes for 20 min. The cell suspension was dispensed into 
Petri dishes (Falcon, Becton Dickinson & Co., Oxnard, CA) and 
exposed to 1 J/cm* of UVA. The irradiation unit consisted of six 
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UVA energy (320-400 nm). Emission in the UVB range was fil- 
tered out by sheet of window glass. Light dose was monitored by a 
photometer (International Light, IL 700A) equipped with a UVA 
probe. The cell suspension was aseptically collected and washed 
twice with PBS to remove the excess 8-MOP. 
Immunization Protocol Recipient mice were injected intra- 
venously in the tail vein with 200 ~1 of PBS containing 30-50 X 
lo6 cells. Among these cells was the in vivo expanded population of 
photoinactivated effector T (PET) ceiis mediating CBA/j skin aiio- 
graft rejection. BALB/c recipients were injected once every week 
for 3 mo. Recipient mice were then tested for T cell unresponsive- 
ness to CBA/j alloantigens in mixed leukocyte culture (MLC), cy- 
totoxicity (CTL), and delayed type hypersensitivity (DTH) assays, 
and challenged with fresh CBA/j skin transplants. 
Mixed Leukocyte Culture The MLC responses were performed 
following modifications of the methods of Rock et al [7] and Kruis- 
beek et al [8]. Erythrocyte-free x-irradiated (1800 rads) skin donor 
stimultor splenocytes (CBA/j) were suspended in media and ali- 
quoted at a concentration of 2 X lo5 cells/well in a volume of 50 ~1. 
Increasing numbers of responder cells (1, 2, 4, and 8 X 105) from 
either naive, sensitized, or PET-treated BALB/c mice were cultured 
in triplicate 2 X lo5 irradiated stimulator cells at a final volume of 
200 ~1 in wells of round-bottom microtiter plates (Corning, Corn- 
ing, NY). Plates were incubated at 37”C, in humidified atmosphere 
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with 1 PCi of 3[H]thymidine for the final 18 h of incubation. Cul- 
tures were harvested with automated culture harvester (MASH, 
Cambridge, MA). Incorporation of radioactivity was measured by 
liquid scintillation counting. Data was presented as delta cpm, 
which represents the allogeneic stimulation response minus the re- 
sponse to autologous irradiated cells. Mean values of six experi- 
ments in triplicates are presented with standard error (SE). In the 
three-party inhibition experiments, increasing numbers of respon- 
der cells (1, 2, and 4 X 105) from either naive, sensitized, or PET- 
treated BALB/c mice were suspended in media and co-cultured 
with stimulator cells. An equivalent amount of cells from either 
PET-treated or sensitized mice was the third population of cells 
added to the wells. Cultures were incubated and harvested as pre- 
viously described. Data was presented as delta cpm. which repre- 
sents the allogeneic stimulation response minus the value obtained 
from the addition of the response to autologous irradiated cells from 
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experiments done in triplicate are given f SE. Percentage of inhibi- 
tion was calculated by the formula: % Inhibition = [ I-(delta cpm of 
sensitized or naive + PET-treated responder cells/delta cpm of 
sensitized + naive responder cells)] X 100. 
Cytotoxicity Assay Skin graft recipient, naive, and PET-treated 
BALB/c mice were killed and a mononuclear cell suspension of 
spleen cells was prepared. Splenocytes from graft recipient mice 
were restimulated in vitro, following the methods of Burakoff et al 
[lo] and Granstein et al [ 111. Briefly, 8 X 1 O6 responder spleen cells 
were co-cultured with 3 X lo6 erythrocyte-free 8-MOP-UVA in- 
activated skin donor strain (CBA/j) splenocytes in 24 well flat-bot- 
tomed microtiter plates (Falcon). Cultures were incubated for 5 d at 
37 ’ C in a humidified atmosphere containing 5% CO,. Cytotoxic- 
ity of effector cells was assessed by testing concanavalin A (Con 
A)-stimulated splenocytes from skin donor mice (CBA/j) or syn- 
geneic mice (BALB/cl as targets. The Con A blasts were prepared 
&2-d &ltu;iof 3 k~;07 s f Izen cells in the presence of 2.5 pg/ml of Con A (Sigma Chemica Co., St. Louis, MO). The Con A blasts 
were separated from nonviable cells by Lympholyte M (Accurate 
Chemical, Westbury, NY) gradient flotation. Viable Con A blasts 
were washed twice and used for 51chromium labeling. Labeling of 
the blast cells was performed by incubating 3 X lo7 recovered cells 
with 200 ~1 of NaslCrO, (5 mCi/ml: Amersham Corp., Arlington 
Heights, IL) for 90 min, shaking the suspension every 15 min. 
The chromium release assay was performed in flat-bottomed mi- 
rrr.c;cnr nlenr I~%l~nm\ h.7 the -JArinn nf 1 ?( 104 =C&?&d tar- t_.IVCI~s,I y.“ca \’ P’C”.., Y, .a._ ~.......YI. VI 
get cells to 1, 2, 4, and 8 X lo5 effector cells in a total volume of 
200 ~1 of media. The plates were centrifuged (300 g, 1 min) at the 
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Table I. Autologous Mixed Leukocyte Response: cpm [3H] thymidine (X i- SE) 
Number of responderb H-2 and Mls haplotype 
cells X IO5 stimulator celk Naive BALB/c Sensitized PET-treated 
(H-2d, Mlsb) (2 x 105) mice (n = 3) BALB/c (n = 3) BALB/c (n = 6) 
1 H-2d Mlsb 250 + 73 281 + 32 4907 + 620 
2 H-2d Mlsb 806 + 39 1630 + 293 32045 + 3811 
4 H-2d Mlsb 5577 + 1044 7767 + 715 46820 + 2339 
8 H-2d Mlsb 14980 + 787 15087 + 627 45147 + 5044 
1 These results are the background values for experiments presented in Tables II, III, and V. 
b The responder cell population (naive, sensitized, or PET-treated BALB/c splenocytes) were aliquoted at increasing concentrations of cells/well in triplicate and tested for [‘HI 
thymidine incorporation. 
c X-irradiated splenocytes from naive BALB/ c mice were aliquoted as stimulator cells at 2 X lo5 cells/well. 
beginning of the assay, incubated for 4- 5 h at 37°C and centri- 
fuged again (500 g, 15”C, 10 min). A volume of 100 ~1 of media 
was removed from each well and dissolved in 3 cc of Biocount 
(Research Products International Corp., Mt. Prospect, IL) for liquid 
scintillation counting. Percentage of specific Wr release was calcu- 
lated according to the formula E-S/M-S X 100, in which E is the 
isotope release in the presence of effector cells, S is the spontaneous 
isotope release in the presence of medium, and M is the maximal 
reiease obtained by adding to target ceiis an equai voiume of 1% 
Triton X-100. The results are reported as the mean percentage of 
specific release of three experiments performed in triplicate with 
spontaneous release of the isotope not higher than 20%. Inhibition 
experiments were performed by culturing 4 X lo6 splenocytes from 
either naive or sensitized mice mixed with 4 X lo6 splenocytes 
from PET-treated mice in the presence of 3 X lo6 S-MOP - UVA 
inactivated splenocytes from skin donor mice (CBA/j). Chro- 
mium-labeled targets were prepared as described above. Determina- 
tion of the Wr specific release was performed and reported as 
previously described. 
Delayed Type Hypersensitivity Response The DTH assay was 
performed following the methods of Granstein et al [ 1 I] and Van 
der Kwast et al [ 121. Spleen cell suspension from CBA/j mice (30- 
50 X lo6 x-irradiated splenocytes) were injected in the flank of five 
naive BALB/c mice (positive control group), five PET-treated 
BGLB’r m’rp (experimen~zi grr?q:, ?), and fVp _RAL_R/C mkP 
I - ------ 
treated with photoinactivated naive splenocytes (experimental 
group 2). For elicitation, the previously immunized groups of mice 
as well as five naive BALB/c mice (negative control group) received 
10 X lo6 CBA/j pl s enocytes injected subcutaneously in the right 
hind footpad in 0.20 ml of PBS. After 24 h, both hind footpads 
were measured for thickness with a dial caliper (Monostat, Swiss- 
made Fisher Scientific, Springfield, NJ). The thickness of the left 
footpad (noninjected) was substracted from the right (injected) 
footpad to measure the DTH response. Percent suppression was 
caicuiated by the formula: i-(E-N/P-N) X iO0, where E is the 
measurement obtained from the experimental group of mice, N is 
the negative control, and P is the positive control. Specific suppres- 
sion of the DTH response was determined by immunizing and 
challenging analogous groups of mice with splenocytes from 
C57Bl/lO mice (H-2b). 
Statistical Analysis Statistical significance was determined ac- 
cording to Student’s t-test. A p value of less than 0.05 was consid- 
ered significant. 
RESULTS 
Specific Suppression of Mixed Leukocyte Culture BALB/c 
female mice, immunized with syngeneic PET cells, demonstrated a 
highly significant (p < 0.001) autologous response (Table I) at all 
numbers of responder cells tested and also showed a highly signifi- 
cant hyporesponsiveness to H-2k, Mlsd alloantigen in MLC, when 
compared with the proliferative response of splenocytes obtained 
from rithm naive ITahl.= II\ nr wn&im=A RAT.R/r mire ITcahle ITI\ _- _ -__ _ _ __ -_ - - -__ . _ \ __--_ __, __ “___“______ -__--, _ ______ \__--_ ___,. 
However, when splenocytes from PET-treated BALB/c mice were 
exposed in MLC to H-2b, Mlsb, an irrelevant alloantigen, the prolif- 
erative response was comparable with that of splenocytes from sen- 
sitized BALB/c mice (Table IV). Therefore, specific hypoprolifera- 
tive response in MLC to the relevant MHC antigens could be 
induced by immunization with PET cells. Thus, this specific hypo- 
responsiveness could be the result of deletion of the effector cell 
population mediating the recognition of the target alloantigen or 
inhibition of the effector cells mediated by a suppressive cell popula- 
tion in the spieens of PET-treated mice. Therefore, a three-party 
MLC was performed to determine whether the MLC hyporespon- 
siveness resulted from a deletion of the effector cell population or 
whether an inhibitory cell population had been generated (Tables V 
and VI). As anticipated, when splenocytes from sensitized BALB/c 
mice were admixed equally (1:l) with splenocytes from naive 
BALB/c mice and then stimulated with CBA/j, an augmented pro- 
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tained. When splenocytes from mice pretreated with PET cells 
were similarly admixed with cells from naive mice, however, the 
proliferative response was markedly suppressed (> 100%) (Table 
V). Similar results were obtained after admixing the splenocytes 
from PET-treated mice with the cells from sensitized mice (Table 
V). When splenocytes from sensitized and PET-treated mice were 
admixed and exposed to x-irradiated cells bearing the irrelevant 
antigen H-2b, Mlsb some suppression was observed (lowest p < 
0.02) (Table VI), however, but not to the extent of the suppression 
demonstrated to the H-2’, Mis” aiioantigen (p < O.OOij (Tabie Vj. 
Therefore, the diminution of MLC reactivity against donor anti- 
gens in splenocytes from PET-treated mice resulted from the pres- 
ence of a specific inhibitory cell population. 
Suppression of Cytotoxicity To evaluate the capacity to gener- 
ate cytotoxic T cells from the spleens of PET-treated BALB/c mice, 
51Cr labeled CBA/j or BALB/c lymphoblasts were added to an 
established BALB/c versus CBA/j MLC assay (Fig 1). Although a 
Table II. Mixed Leukocyte Response: Acpm [3H] thymidine (X + SE)* 
Number of responderb H-2 and MIS haplotype 
cells X IO5 stimulator ceIlsc 
(H-2d, Mlsb) 
Naive BALB/c 
(2 x 105) 
PET-treated BALB/c 
mice (n = 3) Mice (n = 6) p value 
1 H-2’ Mlsd 5223 + 1241 4907 + 620 NS 
2 H-2’ Mlsd 18925 + 1734 7448 + 436 < 0.001 *. -0. . _I , ^^^. . ^_^^ 
ii 
H-L= MIS” 50044 + 2 IOY 
____ _-- 
llwi + 357 <o.ow 
H-2’ Mlsd 26410 + 2008 13928 + 542 <O.OOl 
* The data are presented as Acpm [‘HI thymidine using background values reported in Table I. 
b Responder cells from naive or PET-treated BALB/c mice were &quoted at increasing numbers of responder cells in triplicate and tested for [‘HI thymidine incorporation. 
c X-irradiated splenocytes from CBA/j mice were aliquoted as stimulator cells at 2 X lo5 cells/well. 
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Table III. Mixed Leukocyte Response: Acpm [3H] thymidine (X + SE)* 
--. -.- -..- .- _ _--_- 
Number of responderb H-2 and MIS haplotype Sensitized PET-treated 
cells X lo5 stimulator cellsc BALB/c mice RALB/c mice 
(H-2d. Mlsb) (2 x 105) (n = 6) (n = 6) p value 
-_~ ~..- -~~-~ _- - - --. -. ---- 
1 H-2d MIS’ 10346 + 1679 4907 + 620 <O.OOl 
2 H-2k Mlsd 21902 + 477 7448 -I- 436 <O.OOl 
4 H-2k Mlsd 29660 + 2426 7835 + 357 <O.OOl 
8 H-2’ Mlsd 22152 + 947 13928 + 542 <O.OOl -.---- _ - - _.~. -.--- ~.. 
* The resultant camts are Acpm values after substraction of background counts reported in Table I. 
b Responder cells from sensitized or PET-treated BALB/c mice were &quoted at increasing numbers of responder cells in triphate and tested for /‘HI thymidine incorporation. 
c CBA/j splenocytcs were x-irradiated and &quoted as stimulator cells at 2 X 10’ cells/well. 
maximal specific cytotoxic T cell response of 30% was obtained at 
8O:l E:T ratio from PET-treated BALB/c mice to Wr labeled 
CBA/j targets, this response was significantly less than that ob- 
served in naive BALB/c splenocytes at 20, 40, and 8O:l E:T ratio 
(p < 0.002, <0.005. and <0.005, res 
ze 
ctively) to identical 51Cr 
labeled CBA/j targets. Also, the specs c cytotoxic T cell response 
observed in spleen cells from PET-treated BALB/c mice was signif- 
icantly less than that of sensitized BALB/c mice at 10.20, and 80: 1 
E:T ratio ( < 0.005, <O.OOl, and <O.OOl, respectively) (Fig la). 
There was P ess that 25% cytotoxic response elicited from the spleens 
of naive, sensitized, or PET-treated mice to BALB/c 51Cr labeled 
target cells (Fig 1 b). Therefore, specific hyporesponsive cytotoxic T 
cell response to the original alloantigen presented by the skin graft 
can be observed in the spleen cells of PET-treated mice. Thus, a 
three-party slCr release assay was performed to determine whether 
the diminished cytotoxic response to CBA/j alloantigen from the 
spleens of PET-treated BALB/c mice was the result of an inhibitory 
cell population or the deletion of the effector T cell population (Fig 
2). First, splenocytes from naive BALB/c mice were admixed at a 
1: 1 ratio with cells from the PET-treated BALB/c mice and then 
incubated with CBA/j stimulators. The subsequent addition of 
51Cr-labeled CBA/j target lymphoblasts revealed a significant sup- 
pression at 40 and 8O:l E:T ratio (p < 0.02 and <0.002, respec- 
tively) of the normally pronounced cytotoxic T cell response of 
naive BALB/c mice splenocytes to the CBA/j alloantigen (Fig 20). 
Highly significant suppression (p < 0.005, <O.OOS, <O.OOl, and 
< O.OOl), at all E:T ratios tested, of the sensitized BALB/c cytotoxic 
T cell response to CBA/j 11 a oantigen was obtained when cells from 
the sensitized BALB/c mice were admixed with splenocytes from 
the PET-treated BALB/c mice in the presence of inactivated CBA/j 
splenocytes (Fig 2b). The minimal autologous cytotoxic response of 
25% observed at 80: 1 E:T ratio in splenocytes from naive BALB/c 
mice was also significantly suppressed (p < 0.002) by the addition 
of cells from PET-treated mice (Fig 36). The autologous cytotoxic 
T cell response observed in splenocytes from sensitized BALB/c 
mice was also suppressed (Fig 36), but not to a significant level. 
Therefore, preex 
P 
osure of the immune system to PET cells resulted 
in augmented ce l-mediated inhibition of the cytotoxic T cell re- 
sponse to alloantigen. 
Specific Inhibition of Delayed-Type Hypersensitivity The 
DTH experiments were performed to demonstrate in vivo inhibi- 
tion of the response to alloantigen (Fig 4). When PET-treated mice 
were primed on the flank and 7 d after the footpad challenged with 
H-2k, Mlsd alloantigen-bearing lymphocytes, an 86% suppression 
of the DTH response (footpad swelling) was demonstrated as com- 
pared with positive controls. No suppression of the DTH response 
was demonstrated, however, when PET-treated mice were primed 
and challenged with lymphocytes bearing the unrelated antigen 
H-2b. 
When BALB/c mice treated with photoinactivated naive cells 
were primed in the flank and 7 d after the footpad challenged with 
H-2k, Mlsd alloantigen-bearing lymphocytes, no suppression of 
DTH response (footpad swelling) was demonstrated as compared 
with controls (Fig 5). 
Allograft Retention Finally, BALB/c mice that had been repeat- 
edly infused with PET cells recognizing the H-2k, Mlsd (CBA/j) 
alloantigen were challenged with a fresh CBA/j skin transplant, the 
survival of which was visually and histopathologically followed. Six 
PET-treated BALB/c female mice received CBA/j skin transplants, 
in parallel with naive BALB/c female mice that also received iden- 
tical skin grafts. Treated mice continued to receive intravenous PET 
infusions on a weekly basis, after engraftment. 
AlI control naive BALB/c mice demonstrated evidence of rejec- 
tion by 7 d after transplant. In contrast, none of the PET-treated 
mice demonstrated any visual evidence of rejection. Three PET- 
treated mice were killed 18 d posttransplantation. Their skin grafts 
did not show visual evidence of rejection at that time, whereas 
100% of the control mice transplants had already completely ne- 
crosed. 
The surviving PET-treated mice were killed at subsequent inter- 
vals for histologic evaluation of the graft. Although these mice did 
Table IV. Specificity of Mixed Leucocyte Response: cpm [‘HI thymidine (X + SE)’ --..-~ ._.~ - _. __. _- _.--. 
Number of responderb H-2 and Mls haplotype 
cells X lo5 stimulator cellsc Sensitized PET-treated BALB/c 
(H-2d, Mlsb) (2 x 105) mice (n = 3) mice (n = 3) p value 
_..--._ .-.--~-. .-- _--.-._- - _-.. -. ._-. 
1 H-2d Mlsb 342 + 34 1166+90 <O.OOl 
2 H-2d MIsb 2669 + 508 5586 + 554 <0.02 
4 H-2d Mhb 8959 + 586 14064 + 1310 < 0.02 
8 H-2d Mlsb 15125 + 729 25276 + 576 <O.OOl 
H-2d, Mlsbc kb~~,~l& dhaplotype Acpm [‘Hl’thymidine (X + SE) p value 
1 2967 + 581 3718 + 620 NS 
2 H-2b Mlsb 13589 + 400 10991 + 1329 NS 
4 H-2b Mlsb 19425 + 1202 23488 + 1329 NS 
8 H-2b MIS” 44306 + 2076 49321 + 2076 NS 
~_. -- -- _.-.- _ - -. ._ _. _-...- - 
* These nre the background results. 
b Increasing numbers of responder cells from either sensitized or PET-treated BALB/ c mice were &quoted in triplicate and tested in [‘HI thymidine incorporation. 
c X-irradiated naive BALB/c splenoeytes were aliquoted as stimulator cells at a 2 X 10’ cells/wells. 
d X-irradiated Ill0 (H-2”. MIS”) were ahquoted as stimulator cells at a 2 X 10’ cells/well. 
* Increasing numbers of responders cells from either sensitized or PET-treated BALB/c mice (H-2d, Ml+) were &quoted in tnplicate and tested for [‘HI thymldine incorporatmn. 
‘The results are reported as Acpm values using previous background results. 
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Table V. Inhibition of Mixed Leukocyte Response 
cpm WI Haplotype 
thymidine stimulator 
(X + SE)’ cellsb 
Naive BALB/c (n = 3) 
Naive BALB/c (n = 3) 
Naive BALB/c (n = 4) 
% suppression* 
p value 
Sensitized BALB/c (n = 6) 
Sensitized BALB/c (n = 3) 
Sensitized BALB/c (n = 4) 
% suppression* 
p value 
H-2’Mls* 
H-2kMlsd 
H-2kMlsd 
Additional 
cell 
population’ 1 
- 5223 + 1241 
+ PET-treated - 
+ Sensitized - 
- 10346 + 1679 
+ PET-treated - 
-I- Naive - 
Number of responder cells (H-2*, Mlsb) 
2 4 8 
18925 + 1734 
16262 + 2625 
18105 + 3497 
11% 
NS 
21902 + 477 
18138 + 557 
18105 + 3497 
0% 
NS 
30044 + 2709 
-4057 + 263 
43784 + 3571 
109% 
< 0.001 
29660 + 2426 
11734 + 258 
43784 + 3571 
73% 
<O.OOl 
26410 + 2008 
-30513 + 886 
28184 + 2353 
200% 
<O.OOl 
22152 + 947 
-26136 + 2822 
28184 + 2353 
193% 
<O.OOl 
a The naive or sensitized responder cell population (H-2d, Mlsb) was &quoted at increasing concentration of responder cells/well in triplicate. 
b Splenocytes from CBA/j mice (H-2L, Ml&) were x-irradiated and &quoted at 2 X lo5 cells/well as stimulator cells. 
c For the third party MLC experiments, two distinct populations of syngeneic cells (as indicated) were admixed at a 1: 1 ratio and exposed to stimulator cells and tested for [sH] 
thymidine incorporation. The background values used are reported in Table I. 
d Percent of suppression is calculated from the formula: 
cpm naive or sensitized + PET cells 
cpm naive + sensitized cells >I x 100 
not demonstrate clear visual evidence of rejection by the end of the 
third and seventh wk, respectively, the histopathology evaluation 
performed at the third wk, posttransplantation revealed epidermo- 
tropism of mononuclear inflammatory cells within a viable epi- 
dermis. Confluent and focal vacuolar epidermal basal cell degenera- 
tion, and focal areas of mononuclear cell infiltration of engrafted . . . 
eprdermis with a denser dermal mononuclear cell infiltrate were 
seen in the pathologic specimens obtained from the fifth and se- 
venth wk postengraftment. However, four BALB/c mice that had 
received similar amounts of photoinactivated splenocytes from syn- 
geneic mice rejecting a CBA/j skin graft, then received a skin graft 
from BlO mice that was rejected within 7 d postengraftment. The 
histologic evaluation of these skin grafts revealed separation of a 
necrotic epidermis from the dermis, which contained a very dense 
mononuclear cell infiltrate and thrombi formation within dermal 
vessels. 
Therefore, preexposure of the mouse immune system to PET 
cells generated during skin transplant rejection rendered the sec- 
ondary syngeneic recipient relatively, but not necessarily absolutely, 
tolerant to the alloantigen carried by the transplanted donor used to 
generate the immunizing effector cell population. In spite of these 
in vivo lymphoid infiltrates suggesting a cellular response to the 
graft, substantial suppression of MLC, CTL, and DTH was demon- 
strated, and prolongation of specific allograft survival was observed. 
DISCUSSION 
After the introduction of an histoincompatible tissue transplant, 
populations of delayed type hypersensitivity (Tdth) and cytotoxic 
effector T cells (Tc) are expanded, and antibody directed against the 
graft antigens is produced. This immune response leads to the de- 
struction and rejection of the transplanted tissue [13]. Class I and 
class II cell surface molecules encoded by genes within the major 
histocompatibility complex serve as the main targets of allogeneic 
responses between genetically unrelated individuals [14]. The Tdth 
responses are largely directed at class II antigens (IS], and Tc are 
mainly directed at class I molecules [16]. The antigen binding re- 
ceptor for target class I and II molecules is the relevant T cell recep- 
tor [17]. 
Prolonged survival of skin allografts is difficult to achieve because 
of the particularly vigorous host immune response to histoincompa- 
tible antigens associated with this organ. Therefore, the efficacy of 
protocols intended to inhibit the effector T cells mediating rejection 
of skin allografts can be demonstrated in this sensitive system. An- 
dersson et al [ 181 h ave reported that specific immune unresponsive- 
ness can be induced in vivo in rodents by immunizing the animal 
with autologous antigen-specific lymphoblasts obtained after in 
vitro sensitization, fractionation, and emulsification in Freund’s 
complete adjuvant. Thus, autoimmunization against clonotypic de- 
terminants, presumably of the T cell receptor for a given potent 
antigen, may constitute an efficient way of producing specific im- 
mune tolerance in immunocompetent adult animals. 
To selectively inhibit the response to alloantigen, we exploited 
the observation that the antigen receptor of effector T cells can be 
immunogenic and that specific reactions against T cell receptor can 
suppress its function [19]. T o inhibit the proliferation of the effector 
cells of allogeneic responses, we selected a pharmacologic method 
of photoinactivation by treating the cells with 8-MOP and UVA, 
which would permit retention of an intact cell membrane. The 
~-MOP, a naturally occurring furocoumarin (found in figs, limes, 
and parsnips), has the remarkable capacity of being activated by 
UVA from a biologically inert form to one capable of forming 
covalent bonds with pyrimidine bases of DNA [20]. The DNA 
Table VI. Specificy of Inhibition of Mixed Leukocyte Response 
Acpm [3H] Haplotype Additional 
thymidinea stimulator cell 
Number of responder cells (H-2*, Mlsb)’ 
(X + SE) cellsb populationc 1 2 4 8 
Sensitized BALB/c mice (n = 3) H-2bMlsb - 2967 + 580 13589 + 400 19425 + 1202 44306 + 1528 
Sensitized BALB/c mice (n = 3) H-2bMlsb + PET-treated - 16987 + 878 28297 + 1164 32715 + 2487 
Sensitized BALB/c mice (n = 3) H-2bMlsb + Naive - 24257 + 3096 43041 + 4495 41808 + 2191 
% suppression* 30% 34% 22% 
p value NS < 0.02 <0.05 
a Increasing numbers of responder cells from either sensitized or PET-treated BALB/c mice were aliquoted in triplicate. 
b X-irradiated BlO (H-2b, Mlsb) splenocytes were aliquoted as stimulator cells at 2 X 10s cells/well. 
c For the third-party MLC experiments, two distinct populations of syngeneic cells were admixed at a 1: 1 ratio (as indicated) and exposed to stimulator cells and tested for [sH] 
thymidine incorporation. The background values used are reported in Table IV. 
d Percent of suppression is calculated for the formula previously described in Table V. 
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Figure 1. Cytotoxic response of splenocytes from BALB/c mice. (a) Sensi- 
tized BALB/c splenocytes were reexposed in vitro to H-2k, Mlsd alloantigen. 
Naive BALB/c and PET-treated mice splenocytes were exposed in vitro to 
H-2’, Mlsd alloantigen and all splenocytes tested for lysis of srCr labelled 
CBA/j or (b) BALB/c targets at increasing effector to target ratios. 
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Figure 2. Inhibition of the specific cytotoxic T cell response. (a) Naive 
BALB/c mice splenocytes or (b) sensitized BALB/c splenocytes exposed to 
H-2L, Mlsd alloantigens in vitro and tested for lysis of CBA/j srCr labeled 
targets at increasing effector to target ratios and compared to lysis elicited 
when cells from PET-treated mice were admixed 1: 1 to (a) naive BALB/c or 
(b) sensitized BALB/c mice splenocytes. 
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Figure 3. Inhibition of autologous cytotoxic T cell response. (a) Naive 
BALB/c mice splenocytes or (b) sensitized BALB/c mice splenocytes ex- 
posed to H-2’, Mlsd alloantigens in vitro and tested for lysis of BALB/c 
(H-2d, Mls”) Wr labeled targets at increasing effector to target ratios and 
compared to lysis elicited when cells from PET-treated mice were admixed 
1:l to (a) naive BALB/c or (b) sensitized BALB/c mice splenocytes. 
effect induced by 8-MOP is analogous to the chemical impact of a 
bifunctional alkylating agent like mitomycin C. Psoralen photoad- 
dition, however, can be more exquisitely titrated by altering both 
drug level and UVA intensity. The reaction is light dependent and 
temperature independent. We have previously established condi- 
tions for UVA-8-MOP-induced DNA cross-links to maximally 
inhibit mitosis by murine mononuclear cells while simultaneously 
sparing the capacity of lymphocytes to serve as stimulators [6] in 
MLC. This requires an irradiance of 1 J/cm2 UVA in the presence 
of 100 ng/ml of 8-MOP. 
Murine skin transplantation across H-2 barriers results in trans- 
plant rejection principally mediated by activated T lymphocytes of 
the recipient that have recognized histoincompatible antigens on 
POSITIVE CONTROLS 
I 
0 50 
DTH (MM X 102) (X +/-SE) 
10 
Figure 4. Specific inhibition of the delayed type hypersensitivity response. 
PET-treated BALB/c mice primed in the flank and footpad challenged with 
either CBA/j (H-2L, Mlsd) (left) or B10 (H-2b, Mlsb) (right) splenocytes and 
the measurement of footpad swelling compared to the swelling elicited in 
positive and negative controls. 
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Figure 5. Delayed type hypersensitivity response of experimental control 
group #2. BALB/c mice that had received iv. infusions of 8-MOP-UVA 
Photoinactivated syngeneic naive splenocytes were primed in the flank and 
footpad challenged with splenocytes from either CBA/j (left) or B10 (right) 
mice and footpad swelling measurements compared to swelling elicited in 
control mice. 
the transplanted cells [ 131. These reactive T cells have been identi- 
fied as Lytl+2+ [7] and L3T4-t positive [21]. 
In our study, CBA/j mice (H-2k, Mlsd) were selected as skin 
transplant donors because of their disparity in the H-2 locus with 
BALB/c (H-2d, Mlsb) and their stimulatory phenotype in the Mls 
locus, theoretically maximizing the expansion of effector cells. The 
Mls locus is of interest because it is the only known genetic locus 
other than the MHC in which a strong proliferative response is 
observed between unprimed individuals displaying disparity on it 
[22]. The simplest view of the Mls system at present is that it is 
composed of a silent allele (Mlsb) and two independent stimulatory 
alleles (Mls-a and c) [23] and the co-expression of both simulatory 
determinants (Ml+‘“) results in the Mlsd phenotype. By trans- 
planting CBA/j skin onto BALB/c mice, the allografted mice 
should develop Tc effector cells which recognize class I antigens 
and Tdth lymphocytes possibly of the Thl [24] helper cells that 
recognized class II antigens and possibly, L3T4+ cells responding to 
the Mls-modified products of the MHC [25]. We appear to have 
significantly inhibited this response with our PET immunization 
protocol. 
Our data demonstrates that this novel immunization protocol 
leads to the development of significantly diminished responsiveness 
to alloantigen and that this inhibition reflects the presence of cells 
capable of inhibiting the specific response to H-2k, Mlsd alloantigen 
in MLC, CTL, and DTH reactions. Moreover, a substantial increase 
in the length of skin graft survival was obtained. Our findings 
extend those reported in other systems by various investigators [26 - 
281. Rohowsky et al [26] h ave shown that idiotypelike receptors for 
alloantigens on autologous T lymphoblasts stimulate the autolo- 
gous MLC response in resting lymphocytes. In our studies, a sub- 
stantial increase in the autologous MLC response has been observed 
in the splenocytes of PET-treated animals (Table I). Dorsch and 
Roser [27] demonstrated a rapidly recirculating suppressor T cell 
population in animals rendered tolerant to alloantigen by transfu- 
sion of allogeneic bone marrow cells during the neonatal life. These 
cells are capable of adoptively transferring tolerance, in irradiated 
syngeneic recipients, to skin transplants bearing the alloantigens to 
which the original tolerance was induced, without interfering with 
the rejection of an unrelated skin graft. In our system, we have 
demonstrated the presence of a cell population capable of specifi- 
cally ameliorating the response in MLC, CTL, and DTH to the 
antigen used to generate the effector cell population, while sparing 
the response to an irrelevant antigen. Bellgrau et al [28] induced 
tolerance to parental lymphocytes, in F, rats, by immunizing them 
with lymphocytes bearing the MHC receptors for specific parental 
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strain lymphocytes. In an analogous fashion, we induced hypore- 
sponsiveness to alloantigen by immunizing syngeneic mice with 
splenocytes containing cells bearing the MHC receptor for a spe- 
cific histoincompatible antigens carried by the skin graft. 
In this report, we describe a tolerization method that may be 
practical even in a clinical setting. In our studies the host selects the 
appropriate immunoreactive cell type from a mixed splenocyte pool 
that includes an expanded population of effector BALB/c anti- 
CBA/j lymphocytes. These anti-H-2k, Mlsd lymphocytes would be 
the cells most likely to induce a response in the secondary recipient 
naive BALB/c mice, on a mere numerical basis. Moreover, Ben- 
Nun and Cohen [29] have demonstrated that the induction of a 
suppressive clonotypic response is more efficiently attained, if the 
EAE-inducive T cell clones used for vaccination have been activated 
in vitro with the antigen and attenuated either with x-irradiation or 
mytomicin C before reinfusion. If viable EAE-inducing T cell 
clones are intravenously infused, however, acute unset paralysis 
characteristic of EAE developed in the recipient animals. In our 
protocol, we have used in vivo activation by skin grafting to expand 
effector cells and use these cells obtained at the peak of rejection for 
immunization. The anti-H-2k, Mlsd T cell specific contribution to 
these results may be better ascertained after we have cloned, pho- 
toinactivated, and infused them (either alone or in varying ratios 
with bystander splenocytes). Under these conditions, it will also be 
of interest to determine whether nonspecific bystander splenocytes 
exert either an adjuvant or an interference effect. These studies are 
in progress. 
An alternate explanation for the hyporesponsiveness to alloanti- 
gen demonstrated in our studies can be obtained from the work of 
Jenkins and Schwartz [30]. Their studies showed that splenocytes 
coupled with peptide antigens by the chemical cross-linker l-ethyl- 
3-(3-dimethyl-aminopropyl) carboiimide and used as antigen 
presenting cells (APCs), failed to stimulate proliferation by pigeon 
cytochrome c-specific normal T cell clones and instead induce a 
state of long-term unresponsiveness consistent with clonal deletion. 
In our studies, there is a remote possibility of photochemical cross- 
linking between the antigen and the APCs. The original alloantigen 
carried by the skin graft might have been processed within the 
photoinactivated APCs of the spleens subsequently transferred to 
the naive recipient. However, our data consistently demonstrated 
the presence of an antigen-specific inhibitory cell population in the 
spleen of treated mice, thereby making the possibility of clonal 
deletion less likely. Studies currently in progress are directed at 
identifying which photoinactivated splenocytes most effectively 
lead to the antigen-specific suppression. Furthermore, whereas the 
system described in this paper induces an antigenic-specific inhibi- 
tory cell population, the identity of these cells remains to be estab- 
lished. It will be necessary to determine whether they are Ly2+ 
suppressor T cells [31] or Ly2+ anti-receptor anti-MHC cytotoxic 
T cells, as described by Kosmatopoulos et al [32], or the CD8+ cells 
that specifically respond to determinants on the disease-mediating 
T cell clones [33]. 
Two important questions arise in our system: 1) why is photoin- 
activation with ~-MOP so effective in maximizing the develop- 
ment of a specific inhibitory response to alloantigen, in animals into 
which the retreated cells are infused, in comparison with other 
methods o P cell inactivation such as x-irradiation or mytomicin C 
and 2) how can such a specific response be obtained after use of an 
unfractionated splenic cell population? 
One answer may reflect the ability to control two variables (drug 
dose and UVA energy) that limit the chemical reaction to microsec- 
onds [34], and thus make possible meticulous control of the dose-re- 
sponse curve of cellular inactivation to a level not previously attain- 
able. Significantly, 8-MOP - UVA pretreatment of cloned antibasic 
myelin protein T cells [35] was more effective than x-irradiation of 
the same cells for vaccinating rats against the induction of EAE. 
Second, our studies done on the suppression of DTH response to 
sheep red blood cells [36] have demonstrated that 8-MOP-UVA 
treatment of naive population of splenocytes is ineffective in induc- 
ing suppression, indicating that the presence of expanded popula- 
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tion(s) of specific effector T cells are necessary. Third, Laskin et al 
[37] have identified to a specific, saturable, high affinity binding 
sites for &MOP on mice and human cell lines, which might be a cell 
surface binding site that becomes covalently modified by exposure 
to UVA modifying cellular antigenicity. However, it must be em- 
phasized that 8-MOP-UVA pretreatment of effector cells may be 
merely one means of inducing the observed results. 
In summary, we conclude that it is ossible to induce a state of 
hyporeactivity against a specific set o P MHC antigens. Syngeneic 
effector cells with specificity for these antigens can be photoinacti- 
vated and used as immunogens to induce this hyporesponsive state. 
Because a method for photoinactivating effector T cells in analo- 
gous fashion with that used here has been successful in the treatment 
of cutaneous T cell lymphonia patients [4] and is currently being 
tested in other T cell-mediated disorders, our protocol may have 
potential application in the field of transplantation in humans. 
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